Navigation Links
Cardiogenic Shock is the Leading Cause of Death for Heart Attack Patients

ch enrolled 302 patients between 1993 and 1998 at 29 tertiary care centers. All patients were initially treated with medications and IABP to support the circulation and half received immediate angioplasty or bypass surgery. Patients in the medications arm of the trial could undergo angioplasty or bypass surgery at least two days later. One year after treatment, 47 percent of the patients who received the invasive treatments immediately were alive compared to 34 percent of those in the medications group.

Dr. Hochman hopes that more patients with cardiogenic shock will be treated aggressively and she sees some progress. In January the New York State Department of Health began a two-year experiment in which heart attack patients with severe shock would be analyzed separately from the public databases.

Already Dr. Hochman says that she has heard from colleagues that more cardiogenic shock patients are undergoing angioplasty and surgery in New York because physicians aren’t worried about raising their publicly reported surgical and angioplasty mortality rates due to treating many shock patients.

The change was in response to a number of publications that suggested bias by New York physicians against doing invasive procedures in these highest risk patients. One study by Dr. Hochman and colleagues from Albert Einstein College of Medicine and New England Research Institutes showed that shock patients in New York were less likely than patients in other states to be treated aggressively, presumably because of public reporting requirements. The study’s findings were reported at a meeting last year of the American Heart Association.

Research is underway to find new treatments for cardiogenic shock. Dr. Hochman is leading a trial to determine whether a compound called nitric oxide synthase inhibitor can help shock patients by targeting excess nitric oxide production.

(Source: Newswie)
'"/>




Page: 1 2 3

Related medicine news :

1. Cardiogenic Shock: A Heart Attacks Deadly Counterpart
2. Shock it to Heal!!
3. Shock Wave Therapy Increase The Risk Of Diabetes
4. Health Experts Shocked As 11-year-old Girl To Be UKs Youngest Mother
5. Shocked out of drugs?
6. Radioprotective effect of Heat Shock Proteins
7. New Study Finds On/Off Switch for Septic Shock
8. Hong Kong - HIV Test Shock Sparks Warning
9. Cardiogenic Shock: A Heart Attacks Deadly Counterpart
10. Shockwave Lithotripsy is Effective for Pediatric Urolithiasis
11. Is Diabetes the Leading Cause of Kidney Failure in India
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Cardiogenic Shock the Leading Cause Death for Heart Attack Patients

(Date:7/29/2015)... ... July 29, 2015 , ... Potomac Pilates, an elite Washington, D.C. metro area-based ... the Reformer ® by Potomac Pilates. On Thursday, July 30, Potomac Pilates will ... ® by Potomac Pilates will continue to offer the same classes and personal experiences ...
(Date:7/29/2015)... ... July 29, 2015 , ... More ... and service providers of children living with autism will converge upon Penn State ... demographic. , The National Autism Conference will be held Aug. 3-6 at ...
(Date:7/29/2015)... MOUNT LAUREL, NJ (PRWEB) , ... July 29, ... ... Manager Certification’s (the Commission) CCM® credential for a five-year period, expiring November 30, ... of its CCM credential by submitting an application demonstrating the program’s compliance with ...
(Date:7/29/2015)... ... July 29, 2015 , ... According to the Miami ... or alcohol addiction and mental health disorders. Acu-detox may begin taking off in the ... from drug and alcohol addiction. Although acupuncture is not a new practice, it is ...
(Date:7/29/2015)... ... July 29, 2015 , ... Orthopedic surgeons at Lourdes Medical Center of ... Rotator Cuff System, a new implant to treat a common source of shoulder pain ... regeneration of additional tendon tissue, which could allow for faster healing and a decreased ...
Breaking Medicine News(10 mins):Health News:Same Great Pilates Studio, New Brand - Rock the Reformer 2Health News:Penn State Conference to Address Instruction, Success for Children with Autism 2Health News:Commission for Case Manager Certification Receives Re-Accreditation of its CCM® credential from the National Commission for Certifying Agencies (NCCA) 2Health News:Commission for Case Manager Certification Receives Re-Accreditation of its CCM® credential from the National Commission for Certifying Agencies (NCCA) 3Health News:Miami Drug Rehab Introduces Acupuncture to Line of Holistic Healing for Addiction 2Health News:Miami Drug Rehab Introduces Acupuncture to Line of Holistic Healing for Addiction 3Health News:Lourdes Orthopedics First in NJ to Offer Bioinductive Implant for Rotator Cuff Repair 2Health News:Lourdes Orthopedics First in NJ to Offer Bioinductive Implant for Rotator Cuff Repair 3
... supports previous reports that adolescents with bipolar disorder are ... The article appearing in the June Drug and Alcohol ... and the first to include a control group ... risk conferred by other disorders affecting study participants. ...
... are the first to identify two proteins responsible for ... long known that plant cells respond to physical forces. ... response remained a mystery. , As the name ... that respond to mechanical forces such as gravity, pressure, ...
... a leading provider of laser vision correction services ... events., On Tuesday, June 3, 2008, Chief ... Buckey, will participate in the FTN Midwest,Securities Corp. ... York., On Wednesday, June 25, 2008, Alan ...
... ... Safety Month, CHICAGO, June 2 Protecting children during summer,activities ... during the summer months, mowing the lawn can be as routine ... proper safety,precautions are not taken. In fact, nearly 210,000 people -- ...
... diseases, the immune system turns against the body,s own ... apparent reason. Partly because the origins of these diseases ... suffering they inflict is enormous. Now Weizmann Institute scientists ... make it possible to treat autoimmune diseases effectively without ...
... CHICAGO and CARLSBAD, Calif., June 2 Isis,Pharmaceuticals, ... two of the,Company,s partnered oncology drugs were highlighted ... Data from both drugs,highlighted positive activity that supports ... well tolerated up to very high doses.,Results from ...
Cached Medicine News:Health News:Report confirms increased risk of smoking, substance abuse in bipolar adolescents 2Health News:Researchers identify proteins making up mechanosensitive ion channels 2Health News:Researchers identify proteins making up mechanosensitive ion channels 3Health News:More Than Sun Block Required to Protect Kids While Mowing Lawns 2Health News:More Than Sun Block Required to Protect Kids While Mowing Lawns 3Health News:More Than Sun Block Required to Protect Kids While Mowing Lawns 4Health News:Weizmann Institute scientists develop a new approach to treating autoimmune disease 2Health News:Isis' Partners Present Clinical Data on Antisense Drugs at the American Society of Clinical Oncology 2Health News:Isis' Partners Present Clinical Data on Antisense Drugs at the American Society of Clinical Oncology 3Health News:Isis' Partners Present Clinical Data on Antisense Drugs at the American Society of Clinical Oncology 4
(Date:7/29/2015)... VILLAGE, Nev. , July 29, 2015  PDL ... it has entered into a revenue interest assignment agreement ... ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA ) with up ... for royalties on the net revenues of Iclusig ® ... be made in two tranches of $50 million each, ...
(Date:7/29/2015)... , July 29, 2015  Cepheid (Nasdaq: ... an update to Xpert® Carba-R, with the addition ... OXA-232.  The on-demand, molecular test also detects and ... carbapenem resistance, namely KPC, NDM, VIM, IMP-1 and ... as CROs or Superbugs, are a growing and ...
(Date:7/29/2015)... 2015   BioLife Solutions , Inc. (NASDAQ: ... proprietary clinical grade hypothermic storage and ... products for cells and tissues  ("BioLife" or the ... financial results will be released on Thursday, August 6, ... call and live webcast at 1:30 p.m. PT that ...
Breaking Medicine Technology:PDL BioPharma Completes Royalty Transaction with ARIAD Pharmaceuticals 2PDL BioPharma Completes Royalty Transaction with ARIAD Pharmaceuticals 3PDL BioPharma Completes Royalty Transaction with ARIAD Pharmaceuticals 4PDL BioPharma Completes Royalty Transaction with ARIAD Pharmaceuticals 5'Superbug' Test Updated to Identify Newest Carbapenem-Resistant Organisms 2'Superbug' Test Updated to Identify Newest Carbapenem-Resistant Organisms 3'Superbug' Test Updated to Identify Newest Carbapenem-Resistant Organisms 4BioLife Solutions to Report Second Quarter 2015 Financial Results and Provide Business Update on August 6, 2015 2
... 18, 2011 CryoLife, Inc. (NYSE: CRY ... processing company, today announced the expiration of the 20-day ... with Cardiogenesis Corporation ("Cardiogenesis"), whereby CryoLife is conducting a ... shares of Cardiogenesis. During the "go-shop" ...
... Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH ), ... associated with inflammation, today announced that enrollment in the ... Syndromes (ACS) will continue based on the positive outcome ... patient safety data. An independent statistician ...
Cached Medicine Technology:CryoLife Announces Expiration of Go-Shop Period Related to its Proposed Acquisition of Cardiogenesis Corporation 2CryoLife Announces Expiration of Go-Shop Period Related to its Proposed Acquisition of Cardiogenesis Corporation 3CryoLife Announces Expiration of Go-Shop Period Related to its Proposed Acquisition of Cardiogenesis Corporation 4CryoLife Announces Expiration of Go-Shop Period Related to its Proposed Acquisition of Cardiogenesis Corporation 5CryoLife Announces Expiration of Go-Shop Period Related to its Proposed Acquisition of Cardiogenesis Corporation 6CryoLife Announces Expiration of Go-Shop Period Related to its Proposed Acquisition of Cardiogenesis Corporation 7Anthera Pharmaceuticals Successfully Completes Interim Biomarker Analysis of VISTA-16 Study and Third Safety Review of Varespladib Methyl 2Anthera Pharmaceuticals Successfully Completes Interim Biomarker Analysis of VISTA-16 Study and Third Safety Review of Varespladib Methyl 3Anthera Pharmaceuticals Successfully Completes Interim Biomarker Analysis of VISTA-16 Study and Third Safety Review of Varespladib Methyl 4
... as "a quantum leap forward in the evolution ... the Rose K lens has become the world's ... for keratoconus.,Unlike traditional contact lenses, the complex geometry ... mimics the cone like shape of the cornea, ...
... system is winning the hearts of cardiologists ... calm are the operative words for Heartline™. ... same time they and their attending physician ... change in their heart condition is only ...
... proprietary three-dimensional design that conforms to the ... Contour Eyelid Implant is less conspicuous when ... lower edge and rounded lower corners create ... the implant are smoothly polished to ensure ...
The TOPCON SP-2000P Non -Contact Specular Microscope is a new generation of diagnostic accuracy and versatility in non-contact specular microscopy. The SP-2000P can be linked to TOPCON's IMAGEnet sys...
Medicine Products: